Integral Diagnostics Ltd. ( (AU:IDX) ) has shared an announcement.
The Vanguard Group has become a substantial holder in Integral Diagnostics Ltd., acquiring a 5.124% voting power with 19,051,852 ordinary shares. This acquisition signifies a significant investment by Vanguard, potentially impacting Integral Diagnostics’ market position and indicating confidence in the company’s future prospects.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, providing diagnostic imaging services. The company focuses on delivering high-quality radiology services, catering to a wide range of medical needs across various regions.
YTD Price Performance: -21.18%
Average Trading Volume: 1,589,357
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$858.9M
For a thorough assessment of IDX stock, go to TipRanks’ Stock Analysis page.